静脉注射碘对比剂后肾毒性低发生率的前瞻性研究
这项前瞻性队列研究纳入36个月内连续接受低渗性碘帕醇370 mg/ml静脉注射的1541例患者,CI-AKI发生率为2.1%(95% CI 1.5-3.0),他汀类药物与CI-AKI风险降低相关(OR=0.20),抗生素治疗与风险升高相关(OR=2.92),作者认为低渗性碘帕醇肾毒性发生率低。
要点
- 静脉注射低渗性碘帕醇后CI-AKI发生率为2.1%(95% CI 1.5-3.0),且观察到的患者中为一过性。
- 他汀类药物使用与CI-AKI风险降低相关(OR=0.20,95% CI 0.03-0.68)。
- 抗生素治疗与CI-AKI风险升高约三倍相关(OR=2.92,95% CI 1.21-6.36)。
核心结论
- 低渗性碘帕醇静脉给药肾毒性发生率低,即使存在多种合并症或肾功能减退的患者也是如此。
研究设计与样本
- 前瞻性队列研究,纳入36个月内连续接受低渗性碘帕醇370 mg/ml静脉注射的1541例患者,无排除标准;用MDRD方程评估检查前2-10天和检查后24-36小时的eGFR。
诊断标准与关键数值
- CI-AKI定义为eGFR较基线下降≥25%;CI-AKI发生率为2.1%(95% CI 1.5-3.0),采用二项分布估计。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To estimate the incidence of contrast-induced acute kidney injury (CI-AKI) after intravenous (iv) iodinated contrast material (ICM) exposure.
METHODS: This prospective cohort study included all consecutive patients who underwent radiological investigations using low-osmolar iopamidol 370 mg/ml in a regional hospital over a period of 36 months, without any exclusion criteria. The estimated glomerular filtration rate (eGFR) was evaluated using the MRDR equation before (2-10 days) and after (24-36 h) radiological investigations. CI-AKI was defined as a ≥ 25% decrease in eGFR from baseline. CI-AKI incidence was estimated using a binomial distribution. The association between CI-AKI and demographic and clinical characteristics was modeled using logistic regression.
RESULTS: The study included 1541 patients with a median age of 68 (1st-3rd quartiles 58-76) years with various comorbidities, 30% of whom had pre-existing CKD. Patients affected by stage III or IV chronic kidney disease (CKD) received an infusion of 0.9% normal saline (1.0-1.5 ml/kg/h) before and after iso-osmolar iodixanol administration. CI-AKI was observed in 33 patients (2.1%, 95% CI 1.5-3.0). The logistic regression analysis showed that antibiotic and statin therapies were significantly associated with CI-AKI. The probability of developing CI-AKI decreased by 80% in patients taking statins (OR = 0.20, 95% CI 0.03; 0.68) and increased approximately three times in patients with antibiotic therapy compared with those who did not take statins and antibiotics (OR = 2.92, 95% CI 1.21; 6.36).
CONCLUSIONS: Our data suggest that low-osmolar iopamidol carries a low incidence of nephrotoxicity, even in subjects with various comorbid conditions or reduced renal function.
KEY POINTS: • IV administration of ICM carries a low incidence of nephrotoxicity, which was transient in observed patients. • Statin therapy is negatively associated with AKI in patients exposed to ICM. • Pre-existing impairment of renal function is not associated with AKI in patients exposed to ICM.
引用
- Castaldo P, Frascà GM, Brigante F, et al. Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study. Eur Radiol. 2019. PMID: 30989349. doi:10.1007/s00330-019-06147-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。